PATENT CLAIM ANALYSIS

Application Number: 15959521
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "009321"]

Abstract:
The present invention relates to a microvesicle that is derived from nucleated mammalian cells, which are smaller than the nucleated cells. The microvesicles of the present invention can be used in the delivery of a therapeutic or diagnostic substance to specific tissues or cells, and more particularly, relates to microvesicles derived from monocytes, macrophages, dendritic cells, stem cells or the like, which can be used to deliver specific therapeutic or diagnostic substances for treating and/or diagnosing tissue associated with cancer, diseased blood vessels, inflammation, or the like.

Claim (Index 2):
The drug delivery system of  claim 1 , wherein extracellular domains of membrane proteins of the microvesicles are directed toward outside of the microvesicles.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 91.0
- Lexical Diversity: 1.76786
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13807843', '13807683', '14635379', '14775382', '12488110']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7601688835725222
- 35 USC 102 Novelty (BERT): 0.5347791607000906
- Combined Prediction Score: 0.7376299112852791
- Mean Citation Score: 293.169882
- Max Citation Score: 368.9297
- Similarity Product: 278.8772680774689

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test